Microrna 19A/19B for Use in Treating a Pathological Condition Associated with Bone Loss or Reduced Muscle Function
Universitätsklinikum Hamburg-Eppendorf
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,013,755 | Microrna 19A/19B for Use in Treating a Pathological Condition Associated with Bone Loss or Reduced Muscle Function In force · High confidence | Universitatsklinikum Hamburg-Eppendorf | In force | High confidence | ||
| US 11,793,828 | Microrna 19A/19B for Use in Treating a Pathological Condition Associated with Bone Loss or Reduced Muscle Function In force · High confidence | Universitätsklinikum Hamburg-Eppendorf | In force | High confidence |
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Universitätsklinikum Hamburg-Eppendorf.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.